Search Results - "Reinartz, Roman"
-
1
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
Published in Journal of translational medicine (20-03-2019)“…Molecularly targeted therapies using receptor inhibitors, small molecules or monoclonal antibodies are routinely applied in oncology. Verification of target…”
Get full text
Journal Article -
2
Anticancer Effects of Niclosamide in Human Glioblastoma
Published in Clinical cancer research (01-08-2013)“…Glioblastoma is a highly malignant, invariably fatal brain tumor for which effective pharmacotherapy remains an unmet medical need. Screening of a compound…”
Get full text
Journal Article -
3
Residual tumor cells are unique cellular targets in glioblastoma
Published in Annals of neurology (01-08-2010)“…Residual tumor cells remain beyond the margins of every glioblastoma (GBM) resection. Their resistance to postsurgical therapy is considered a major driving…”
Get full text
Journal Article -
4
Targeting the Cytosolic Innate Immune Receptors RIG‐I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in Glioblastoma
Published in Stem cells (Dayton, Ohio) (01-06-2013)“…Cellular heterogeneity, for example, the intratumoral coexistence of cancer cells with and without stem cell characteristics, represents a potential root of…”
Get full text
Journal Article -
5
Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma
Published in European journal of cancer (1990) (01-11-2020)“…The protease inhibitor ritonavir (RTV) is a clinical-stage inhibitor of the human immunodeficiency virus. In a drug repositioning approach, we here exhibit the…”
Get full text
Journal Article -
6
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
Published in Clinical cancer research (15-01-2017)“…Investigation of clonal heterogeneity may be key to understanding mechanisms of therapeutic failure in human cancer. However, little is known on the…”
Get full text
Journal Article -
7
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma
Published in Journal of cancer research and clinical oncology (01-07-2016)“…Purpose Dovitinib (TKI258) is an oral multi-tyrosine kinase inhibitor of FGFR, VEGFR, PDGFR β, and c-Kit. Since dovitinib is able to cross the blood–brain…”
Get full text
Journal Article -
8
Susceptibility variants for male-pattern baldness on chromosome 20p11
Published in Nature genetics (01-11-2008)“…We carried out a genome-wide association study in 296 individuals with male-pattern baldness (androgenetic alopecia) and 347 controls. We then investigated the…”
Get full text
Journal Article -
9
-
10
Genome-wide Scan and Fine-Mapping Linkage Study of Androgenetic Alopecia Reveals a Locus on Chromosome 3q26
Published in American journal of human genetics (01-03-2008)“…Androgenetic alopecia (AGA, male pattern baldness) is the most common form of hair loss. The origin of AGA is genetic, with the X chromosome located androgen…”
Get full text
Journal Article -
11
Genome-wide Scan and Fine-Mapping Linkage Study of And rogenetic Alopecia Reveals a Locus on Chromosome 3q26
Published in American journal of human genetics (03-03-2008)“…Androgenetic alopecia (AGA, male pattern baldness) is the most common form of hair loss. The origin of AGA is genetic, with the X chromosome located androgen…”
Get full text
Journal Article -
12
Susceptibility variants for male-pattern baldness on chromosome 20p11
Published in Nature genetics (2008)Get full text
Journal Article